23024633|t|PDE5 Inhibitors as Potential Tools in the Treatment of Cystic Fibrosis.
23024633|a|Despite great advances in the understanding of the genetics and pathophysiology of cystic fibrosis (CF), there is still no cure for the disease. Using phosphodiesterase type 5 (PDE5) inhibitors, we and others have provided evidence of rescued F508del-CFTR trafficking and corrected deficient chloride transport activity. Studies using PDE5 inhibitors in mice homozygous for the clinically relevant F508del mutation have been conducted with the aim of restoring F508del-CFTR protein function. We demonstrated, by measuring transepithelial nasal potential difference in F508del mice following intraperitoneal injection of sildenafil, vardenafil, or taladafil at clinical doses are able to restore the decreased CFTR-dependent chloride transport across the nasal mucosa. Moreover, vardenafil, but not sildenafil, stimulates chloride transport through the normal CFTR protein. We developed a specific nebulizer setup for mice, with which we demonstrated, through a single inhalation of PDE5 inhibitors, local activation of CFTR protein in CF. Significant potential advantages of inhalation drug therapy over oral or intravenous routes include rapid onset of pharmacological action, reduced systemic secondary effects, and reduced effective drug doses compared to the drug delivered orally; this underlines the relevance and impact of our work for translational science. More recently, we analyzed the bronchoalveolar lavage of CF and wild-type mice for cell infiltrates and expression of pro-inflammatory cytokines and chemokines; we found that the CFTR activating effect of vardenafil, selected as a representative long-lasting PDE5 inhibitor, breaks the vicious circle of lung inflammation which plays a major role in morbi-mortality in CF. Our data highlight the potential use of PDE5 inhibitors in CF. Therapeutic approaches using clinically approved PDE5 inhibitors to address F508del-CFTR defects could speed up the development of new therapies for CF.
23024633	55	70	Cystic Fibrosis	Disease	MESH:D003550
23024633	155	170	cystic fibrosis	Disease	MESH:D003550
23024633	172	174	CF	Disease	MESH:D003550
23024633	223	247	phosphodiesterase type 5	Gene	242202
23024633	249	253	PDE5	Gene	242202
23024633	315	322	F508del	ProteinMutation	tmVar:p|DEL|508|F;HGVS:p.F508del;VariantGroup:0;OriginalGene:12638;CorrespondingGene:1080;RS#:113993960;CorrespondingSpecies:10090;CA#:118639
23024633	323	327	CFTR	Gene	12638
23024633	364	372	chloride	Chemical	MESH:D002712
23024633	426	430	mice	Species	10090
23024633	470	477	F508del	ProteinMutation	tmVar:p|DEL|508|F;HGVS:p.F508del;VariantGroup:0;OriginalGene:12638;CorrespondingGene:1080;RS#:113993960;CorrespondingSpecies:10090;CA#:118639
23024633	533	540	F508del	ProteinMutation	tmVar:p|DEL|508|F;HGVS:p.F508del;VariantGroup:0;OriginalGene:12638;CorrespondingGene:1080;RS#:113993960;CorrespondingSpecies:10090;CA#:118639
23024633	541	545	CFTR	Gene	12638
23024633	640	647	F508del	ProteinMutation	tmVar:p|DEL|508|F;HGVS:p.F508del;VariantGroup:0;OriginalGene:12638;CorrespondingGene:1080;RS#:113993960;CorrespondingSpecies:10090;CA#:118639
23024633	648	652	mice	Species	10090
23024633	692	702	sildenafil	Chemical	MESH:D000068677
23024633	704	714	vardenafil	Chemical	MESH:D000069058
23024633	719	728	taladafil	Chemical	-
23024633	781	785	CFTR	Gene	12638
23024633	796	804	chloride	Chemical	MESH:D002712
23024633	850	860	vardenafil	Chemical	MESH:D000069058
23024633	870	880	sildenafil	Chemical	MESH:D000068677
23024633	893	901	chloride	Chemical	MESH:D002712
23024633	931	935	CFTR	Gene	12638
23024633	989	993	mice	Species	10090
23024633	1091	1095	CFTR	Gene	12638
23024633	1107	1109	CF	Disease	MESH:D003550
23024633	1495	1497	CF	Disease	MESH:D003550
23024633	1512	1516	mice	Species	10090
23024633	1560	1572	inflammatory	Disease	MESH:D007249
23024633	1617	1621	CFTR	Gene	12638
23024633	1643	1653	vardenafil	Chemical	MESH:D000069058
23024633	1742	1759	lung inflammation	Disease	MESH:D011014
23024633	1807	1809	CF	Disease	MESH:D003550
23024633	1870	1872	CF	Disease	MESH:D003550
23024633	1950	1957	F508del	ProteinMutation	tmVar:p|DEL|508|F;HGVS:p.F508del;VariantGroup:0;OriginalGene:12638;CorrespondingGene:1080;RS#:113993960;CorrespondingSpecies:10090;CA#:118639
23024633	1958	1962	CFTR	Gene	12638
23024633	2023	2025	CF	Disease	MESH:D003550
23024633	Association	MESH:D002712	12638
23024633	Negative_Correlation	MESH:D000069058	MESH:D011014
23024633	Association	MESH:D003550	12638
23024633	Association	MESH:D002712	242202
23024633	Negative_Correlation	MESH:D000069058	MESH:D003550
23024633	Negative_Correlation	MESH:D000069058	12638
23024633	Association	MESH:D011014	12638
23024633	Positive_Correlation	MESH:D000069058	MESH:D002712

